Evidence map›Paper›PMID 42698105›Full record

ArticleInfectious diseases of poverty2026

HIV-tuberculosis co-infection in Liangshan, a resource-limited region of Southwest China: trends and implications in the context of integrated prevention, 2019-2024.

Xuefei Bai, Ju Wang, Gang Yu, Jinhong Shi, Sisi Fan, Ruobing Wang, Yubing Wang, Xiaoying Feng, Rong Pei, Rujun Liao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xuefei Bai *Sichuan Center for Disease Control and Prevention, Chengdu, 610041, Sichuan, China.ORCID http://orcid.org/0009-0004-5845-3130
Ju Wang *Liangshan Center for Disease Control and Prevention, Liangshan Yi Autonomous Prefecture, Xichang, 615000, Sichuan, China.ORCID http://orcid.org/0009-0000-2588-6977
Gang YuLiangshan Center for Disease Control and Prevention, Liangshan Yi Autonomous Prefecture, Xichang, 615000, Sichuan, China.
Jinhong ShiSichuan Center for Disease Control and Prevention, Chengdu, 610041, Sichuan, China.
Sisi FanSichuan Center for Disease Control and Prevention, Chengdu, 610041, Sichuan, China.ORCID http://orcid.org/0009-0000-7615-360X
Ruobing WangLiangshan Center for Disease Control and Prevention, Liangshan Yi Autonomous Prefecture, Xichang, 615000, Sichuan, China.
Yubing WangLiangshan Center for Disease Control and Prevention, Liangshan Yi Autonomous Prefecture, Xichang, 615000, Sichuan, China.
Xiaoying FengLiangshan Center for Disease Control and Prevention, Liangshan Yi Autonomous Prefecture, Xichang, 615000, Sichuan, China.
Rong PeiSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China. rongfry@163.com.ORCID http://orcid.org/0000-0002-2876-901X
Rujun LiaoSichuan Center for Disease Control and Prevention, Chengdu, 610041, Sichuan, China. 22233260@qq.com.ORCID http://orcid.org/0000-0001-8528-0846

Funding

Liangshan Prefecture Science and Technology Bureau Program 23ZDYF0025
6 · The paper itself

Abstract

backgroundTuberculosis (TB) and HIV co-infection remains a major public health challenge in resource-limited settings. Liangshan Yi Autonomous Prefecture in Southwest China bears a dual high burden of HIV and TB. This study aimed to analyze the epidemiological trends of HIV-TB co-infection in Liangshan from 2019 to 2024 and to inform integrated prevention strategies.

methodsA retrospective analysis was conducted on 3367 HIV-TB co-infected cases extracted from the National HIV/AIDS and TB surveillance systems. Records were linked via unique identifiers. Descriptive statistics and chi-square tests for trend assessed incidence trends, demographics, transmission routes, treatment outcomes, and drug resistance.

resultsFrom 2019 to 2024, HIV-TB incidence declined from 12.26 to 8.76 per 100,000 (χ

conclusionDuring the implementation of integrated strategies, HIV-TB incidence showed a declining trend, particularly in high-burden areas and younger populations. Persistent challenges-stagnant incidence and poor outcomes in the elderly, high loss to follow-up (10.87%), rising drug resistance-require targeted interventions: leveraging the Yi "clan" (Jiazhi) system, strengthening active screening and nutritional support for older adults, optimizing drug resistance surveillance, and integrating digital health tools.

Indexed as

CoinfectionHIV InfectionsTuberculosisAdolescentAdultAgedChildChinaFemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesYoung AdultChinaCo-infectionDrug resistanceEpidemiological trendHIVIntegrated prevention and controlLiangshan Yi Autonomous PrefectureResource-limited regionTuberculosisYi “clan”(Jiazhi) system

Identifiers

PMID42698105
PMCPMC13543528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.